中国医学前沿杂志(电子版)
中國醫學前沿雜誌(電子版)
중국의학전연잡지(전자판)
CHINESE JOURNAL OF THE FRONTIERS OF MEDICAL SCIENCE(ELECTRONIC VERSION)
2015年
3期
90-94
,共5页
谢桂娟%张辉艳%陈晴%赵博%刘慧敏%张绪清
謝桂娟%張輝豔%陳晴%趙博%劉慧敏%張緒清
사계연%장휘염%진청%조박%류혜민%장서청
药物性肝损伤%肝衰竭%临床特点
藥物性肝損傷%肝衰竭%臨床特點
약물성간손상%간쇠갈%림상특점
Drug-induced liver injury%Liver failure%Clinical characteristic
目的:探索中国西南地区药物性肝衰竭病因构成、临床特征及预后。方法回顾性分析2000~2012年本院收治的66例药物性肝衰竭患者临床资料,所有患者均来自我国西南地区,对其临床特征进行总结。结果66例药物性肝衰竭患者中,急性13例,亚急性43例,慢加急性10例;早期12例,中期27例,晚期27例。引起肝衰竭的主要药物依次为抗结核药物、中草药、免疫抑制剂。西药引起急性药物性肝衰竭12例,亚急性肝衰竭26例,慢加急性3例;中草药引起急性药物性肝衰竭1例,亚急性17例,慢加急性7例。药物性肝衰竭肝细胞损伤型占24.2%(16/66),胆汁淤积型占51.5%(34/66),混合型占24.2%(16/66),中、西药治疗的患者肝损伤类型及预后比较差异均无显著性(P>0.05)。好转与无效者在年龄段、性别、总胆红素、直接胆红素及碱性磷酸酶分布方面比较差异均无显著性(P>0.05);治疗无效患者的并发症发生率均高于好转者,差异均有显著性(P<0.01)。结论在西南地区抗结核药物是引起药物性肝衰竭主要原因,以亚急性多见;肝细胞损伤类型以胆汁淤积型为主;有效积极地预防与治疗肝性脑病及感染等并发症对该类患者预后具有重要意义。
目的:探索中國西南地區藥物性肝衰竭病因構成、臨床特徵及預後。方法迴顧性分析2000~2012年本院收治的66例藥物性肝衰竭患者臨床資料,所有患者均來自我國西南地區,對其臨床特徵進行總結。結果66例藥物性肝衰竭患者中,急性13例,亞急性43例,慢加急性10例;早期12例,中期27例,晚期27例。引起肝衰竭的主要藥物依次為抗結覈藥物、中草藥、免疫抑製劑。西藥引起急性藥物性肝衰竭12例,亞急性肝衰竭26例,慢加急性3例;中草藥引起急性藥物性肝衰竭1例,亞急性17例,慢加急性7例。藥物性肝衰竭肝細胞損傷型佔24.2%(16/66),膽汁淤積型佔51.5%(34/66),混閤型佔24.2%(16/66),中、西藥治療的患者肝損傷類型及預後比較差異均無顯著性(P>0.05)。好轉與無效者在年齡段、性彆、總膽紅素、直接膽紅素及堿性燐痠酶分佈方麵比較差異均無顯著性(P>0.05);治療無效患者的併髮癥髮生率均高于好轉者,差異均有顯著性(P<0.01)。結論在西南地區抗結覈藥物是引起藥物性肝衰竭主要原因,以亞急性多見;肝細胞損傷類型以膽汁淤積型為主;有效積極地預防與治療肝性腦病及感染等併髮癥對該類患者預後具有重要意義。
목적:탐색중국서남지구약물성간쇠갈병인구성、림상특정급예후。방법회고성분석2000~2012년본원수치적66례약물성간쇠갈환자림상자료,소유환자균래자아국서남지구,대기림상특정진행총결。결과66례약물성간쇠갈환자중,급성13례,아급성43례,만가급성10례;조기12례,중기27례,만기27례。인기간쇠갈적주요약물의차위항결핵약물、중초약、면역억제제。서약인기급성약물성간쇠갈12례,아급성간쇠갈26례,만가급성3례;중초약인기급성약물성간쇠갈1례,아급성17례,만가급성7례。약물성간쇠갈간세포손상형점24.2%(16/66),담즙어적형점51.5%(34/66),혼합형점24.2%(16/66),중、서약치료적환자간손상류형급예후비교차이균무현저성(P>0.05)。호전여무효자재년령단、성별、총담홍소、직접담홍소급감성린산매분포방면비교차이균무현저성(P>0.05);치료무효환자적병발증발생솔균고우호전자,차이균유현저성(P<0.01)。결론재서남지구항결핵약물시인기약물성간쇠갈주요원인,이아급성다견;간세포손상류형이담즙어적형위주;유효적겁지예방여치료간성뇌병급감염등병발증대해류환자예후구유중요의의。
Objective To explore the etiology, clinical characteristics and prognosis of drug-induced liver failure in southwest China. Method The clinical data of 66 patients with DILF hospitalized in southwest hospital of China from 2000 to 2012 were retrospectively analyzed. Result Of these 66 patients, 13 cases were acute, 43 cases were subacute and 10 cases were acute on chronic. 12 cases in the early stage, 27 cases in the middle stage and 27 cases in the late stage. Liver failure caused by the main three kinds of drugs were anti-tuberculosis drugs, followed by Chinese medicine, immunosuppressants. 12 cases with acute liver failure, 26 cases with sub-acute liver failure and 3 cases with acute on chronic were induced by western drugs;1 case with acute liver failure, 17 cases with sub-acute liver failure and 7 cases with acute on chronic were induced by Chinese herbs. Hepatocellular type accounted for 24.2%(16/66), cholestasis type accounted for 51.5%(34/66), and hybrid accounted for 24.2%(16/66). Prognosis and liver damage types of Chinese and western medicine had no statistical signiifcance (P>0.05). Improvement and invalid group in age, gender, total bilirubin, direct bilirubin and alkaline phosphatase distribution had no statistical signiifcance (P > 0.05). Treatment failure patients the incidence of complications were higher than that of the improved (P<0.01). Conclusion Anti-TB drugs is the main cause of drug-induced liver failure in the southwest, it familiarly lead to sub-acute liver failure;liver cell damage types are mainly composed of cholestasis type;effective prevention and treatment of hepatic encephalopathy, infection and other complications has an important significance to improve the prognosis in patients with DILF.